The effect of baricitinib add-on therapy in atopic dermatitis patients treated with dupilumab

Dermatol Ther. 2022 Jul;35(7):e15525. doi: 10.1111/dth.15525. Epub 2022 Apr 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Azetidines* / therapeutic use
  • Dermatitis, Atopic* / chemically induced
  • Dermatitis, Atopic* / diagnosis
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • Purines
  • Pyrazoles
  • Sulfonamides

Substances

  • Antibodies, Monoclonal, Humanized
  • Azetidines
  • Purines
  • Pyrazoles
  • Sulfonamides
  • dupilumab
  • baricitinib